Literature DB >> 18162936

RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis.

Virginia Amanatidou1, George Sourvinos, Stavros Apostolakis, Pelagia Neonaki, Amalia Tsilimigaki, Elias Krambovitis, Demetrios A Spandidos.   

Abstract

BACKGROUND: Severe respiratory syncytial virus (RSV) infection is characterized by enhanced chemokine activity. Several studies have linked increased regulated on activation, normal T cell expressed and secreted (RANTES) expression with severe RSV disease. Three single nucleotide polymorphisms, -28C/G, -403G/A, and In1.1T/C in the RANTES gene, have been correlated with the gene's transcriptional activity. In the present study, we explored the possible correlation of the genetic variability of the RANTES gene with the clinical manifestation of RSV disease.
METHODS: DNA samples were obtained from 106 children hospitalized for RSV bronchiolitis, in a 2-year period. One hundred twenty sex-matched healthy adults, without a history of severe lower respiratory tract infections, formed the control group.
RESULTS: No association was established between -28C/G polymorphism and RSV-induced bronchiolitis, mainly because of its extreme rarity in the studied population. No statistically significant differences were observed in cases and controls regarding genotype and allele frequencies of each of the In.1.1T/C and -403G/A polymorphisms. By contrast, the -28C/C-403G/AIn1.1T/T combined genotype was significantly more common in cases than in controls.
CONCLUSIONS: Our results indicate an association between a common genotype with severe RSV infection. This observation supports the previously reported results indicating RANTES as an important mediator of RSV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18162936     DOI: 10.1097/INF.0b013e31814d4e42

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

1.  Exploring the origins of asthma: Lessons from twin studies.

Authors:  Simon Francis Thomsen
Journal:  Eur Clin Respir J       Date:  2014-09-01

2.  Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Authors:  Christy M Tabarani; Cynthia A Bonville; Manika Suryadevara; Patrick Branigan; Dongliang Wang; Danning Huang; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

3.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

Review 4.  Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Authors:  Pingsheng Wu; Tina V Hartert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

Review 5.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Association of Chemotactic Chemokine Ligand 5 Polymorphisms with the Risk of Developing Severe Enterovirus 71 Infection.

Authors:  Mao-Zhong Li; Li-Li Pang; Ai-Ying Bai; Shi-Cheng Yu; Xun Gong; Na Liu; Kun Cai; Guang-Cheng Xie; Wen-Juan Gao; Yu Jin; Zhao-Jun Duan
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

Review 7.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

8.  Effect of variation in RANTES promoter on serum RANTES levels and risk of recurrent wheezing after RSV bronchiolitis in children from Han, Southern China.

Authors:  Man Tian; Feng Liu; Guan-yu Wen; Sheng-yun Shi; Rong-hua Chen; De-yu Zhao
Journal:  Eur J Pediatr       Date:  2008-11-13       Impact factor: 3.183

Review 9.  Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 10.  Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.

Authors:  Farzaneh Darbeheshti; Mojdeh Mahdiannasser; Bruce D Uhal; Shuji Ogino; Sudhir Gupta; Nima Rezaei
Journal:  Rev Med Virol       Date:  2021-03-16       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.